Revvity
RVTY • NYSE
Revvity is a medical - diagnostics & research company in the healthcare sector trading on NYSE, led by CEO Prahlad R. Singh, with a market cap of $9.4B.
CEOPrahlad R. Singh
Next Earnings
Upcoming earnings announcement for Revvity
Date
Monday, April 27, 2026 (in 3 weeks)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.02
Revenue Estimate
$703.2M
Earnings History
Past 12 earnings reports for Revvity
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | Q4 2025 | $1.70Est: $1.58 | +7.6% | $772.1MEst: $766.6M | +0.7% |  10-K |
| Oct 27, 2025 | Q3 2025 | $1.18Est: $1.14 | +3.5% | $698.9MEst: $699.7M | -0.1% | 10-Q |
| Jul 28, 2025 | Q2 2025 | $1.18Est: $1.14 | +3.5% | $720.3MEst: $711.3M | +1.3% | 10-Q |
| Apr 28, 2025 | Q1 2025 | $1.01Est: $0.95 | +6.3% | $664.8MEst: $661.2M | +0.5% | 10-Q |
| Jan 31, 2025 | Q4 2024 | $1.42Est: $1.38 | +2.9% | $729.4MEst: $730.1M | -0.1% | 10-K |
| Nov 4, 2024 | Q3 2024 | $1.28Est: $1.13 | +13.3% | $684.0MEst: $679.7M | +0.6% | 10-Q |
| Jul 29, 2024 | Q2 2024 | $1.22Est: $1.12 | +8.9% | $691.7MEst: $690.4M | +0.2% | 10-Q |
| Apr 29, 2024 | Q1 2024 | $0.98Est: $0.93 | +5.4% | $649.9MEst: $646.8M | +0.5% | 10-Q |
| Feb 1, 2024 | Q4 2023 | $1.25Est: $1.16 | +7.8% | $695.9MEst: $677.9M | +2.6% | 10-K |
| Oct 30, 2023 | Q3 2023 | $1.18Est: $1.19 | -0.8% | $670.7MEst: $695.5M | -3.6% | — |
| Aug 1, 2023 | Q2 2023 | $1.21Est: $1.18 | +2.5% | $709.1MEst: $705.2M | +0.6% | 10-Q |
| May 11, 2023 | Q1 2023 | $1.01Est: $1.06 | -4.7% | $674.9MEst: $751.0M | -10.1% | — |